[HTML][HTML] Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantation

J Sawyer, T Elliott, L Orton, H Sowell… - Clinical Hematology …, 2024 - ncbi.nlm.nih.gov
Hematopoietic stem cell transplantation (HSCT) remains the only curative option for several
hematological malignancies. Its use has continued to grow, with an estimated 23,500 …

Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantation

J Sawyer, T Elliott, L Orton, H Sowell… - Clinical …, 2024 - pubmed.ncbi.nlm.nih.gov
Hematopoietic stem cell transplantation (HSCT) remains the only curative option for several
hematological malignancies. Its use has continued to grow, with an estimated 23,500 …

[HTML][HTML] Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantation

J Sawyer, T Elliott, L Orton, H Sowell… - Clinical Hematology …, 2024 - chi.scholasticahq.com
Hematopoietic stem cell transplantation (HSCT) remains the only curative option for several
hematological malignancies. Its use has continued to grow, with an estimated 23,500 …

Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantation.

J Sawyer, T Elliott, L Orton, H Sowell… - Clinical Hematology …, 2024 - europepmc.org
Hematopoietic stem cell transplantation (HSCT) remains the only curative option for several
hematological malignancies. Its use has continued to grow, with an estimated 23,500 …

[HTML][HTML] Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantation

J Sawyer, T Elliott, L Orton, H Sowell… - Clinical Hematology …, 2024 - chi.scholasticahq.com
Hematopoietic stem cell transplantation (HSCT) remains the only curative option for several
hematological malignancies. Its use has continued to grow, with an estimated 23,500 …